Skip to content
Glenmark Pharmaceuticals
Global
Menu
Close
Global
US
India
Europe
Latin America
ROW
Asia
Malaysia
Australia
Me & Africa
Russia & CIS
Global
US
India
Europe
Latin America
ROW
Asia
Malaysia
Australia
Me & Africa
Russia & CIS
Connect with Us
Global Presence
Contact Us
Global Presence
Contact Us
Be a part of our
global growth story
To improve patient lives
About us
Our Journey
Board of Directors
Leadership
Governance
Manufacturing
R&D
Innovation
Overview
Pipeline
Partnership
Products
Portfolio
Top Products
Responsibility
Corporate Social Responsibility
Sustainability
Investors
Financials
Disclosures under Regulation 46 of SEBI LODR
Investor Resources
Other announcements
News
Press Release
Media Library
Careers
Life at Glenmark
Glenmark Centre for Learning
Join Us
Toggle website search
Impact Assessment Reports
Impact Assessment Report FY 2023-24
Impact Assessment Report FY 2022-23
Impact Assessment Report FY 2021-22
Impact Assessment Report FY 2020-21
Impact Assessment Report FY 2019-20
